SCHEMBL4199901

SCHEMBL4199901

CCCCCCCCCCN(CCCCCCCCCC)C(=O)CCN

nearest known ligand 0.51

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CA12 O43570 2/20 0.44
CA1 P00915 2/20 0.44
CA2 P00918 2/20 0.44
CA9 Q16790 1/20 0.44
ALDH1A1 P00352 2/20 0.42
HPGD P15428 1/20 0.42
MMP1 P03956 1/20 0.42
MMP2 P08253 1/20 0.42
MMP3 P08254 1/20 0.42
MMP8 P22894 1/20 0.42
CA4 P22748 1/20 0.42
CES2 O00748 3/20 0.41
CES1 P23141 3/20 0.41
ACHE P22303 1/20 0.41
DNM1 Q05193 4/20 0.41
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41
TSHR P16473 1/20 0.41
EPHX1 P07099 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4205873 1.00 CA12 (0.44) CA12CA1CA2CA9ALDH1A1
SCHEMBL4194719 1.00 CA12 (0.44) CA12CA1CA2CA9ALDH1A1
SCHEMBL31050952 0.90 DNM1 (0.44) CA12CA1CA2ALDH1A1CA4
SCHEMBL26048394 0.90 DNM1 (0.44) CA12CA1CA2ALDH1A1CA4
SCHEMBL3486793 0.90 FAAH (0.54) MMP2MEN1KMT2A
SCHEMBL27538272 0.89 KDM5A (0.45) ALDH1A1CES2CES1ACHEMEN1
SCHEMBL28424085 0.89 ACHE (0.49) ALDH1A1ACHEDNM1MEN1KMT2A
SCHEMBL8015904 0.87 CA12 (0.50) CA12CA1CA2CA9ALDH1A1
SCHEMBL10727436 0.87 CA12 (0.50) CA12CA1CA2CA9ALDH1A1
SCHEMBL6708723 0.87 CA12 (0.50) CA12CA1CA2CA9ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118184538-B Lung high-expression cationic lipid compound, composition containing same and application 北京悦康科创医药科技股份有限公司 2024-08-16 CN disclosed
CN-118184538-A Lung high-expression cationic lipid compound, composition containing same and application 北京悦康科创医药科技股份有限公司 2024-06-14 CN disclosed
US-20090011946-A1 Use of Sequence Specific Polymers in Chemical Detection KALINEX (US) 2009-01-08 US disclosed
EP-1839059-A1 USE OF SEQUENCE SPECIFIC POLYMERS IN CHEMICAL DETECTION Kalinex (US) 2007-10-03 EP disclosed
WO-2006069263-A1 USE OF SEQUENCE SPECIFIC POLYMERS IN CHEMICAL DETECTION KALINEX (US) 2006-06-29 WO disclosed
US-20050003558-A1 Biological sample component purification and differential display CHIRON CORPORATION (US) 2005-01-06 US disclosed
US-6783929-B1 COMPRISES POLYAMIDE LIGANDS FOR ENHANCED EFFICIENCY OF PROTEOMICS CHIRON CORPORATION 2004-08-31 US disclosed
EP-1155327-A1 BIOLOGICAL SAMPLE COMPONENT PURIFICATION AND DIFFERENTIAL DISPLAY CHIRON CORPORATION (US) 2001-11-21 EP disclosed
WO-2001033230-A2 BIOLOGICAL SAMPLE COMPONENT PURIFICATION AND DIFFERENTIAL DISPLAY CHIRON CORPORATION (US) 2001-05-10 WO disclosed